Kellie Rodriguez Outlines the Role of a Diabetes Educator With Financial Challenges
June 15, 2019 – 
Diabetes educators can help patients with diabetes who face financial challenges make appropriate choices and receive assistance to afford medications, said Kellie Rodriguez, RN, MSN, MBA, CDE, director, Global Diabetes Program, Parkland Health & Hospital System.
Dr Stella Safo Discusses the Impact of Value-Based Care on People Living With HIV
June 14, 2019 – 
HIV care delivery has always had an ethos in it of really being based on a team-based approach, explained Stella A. Safo, MD, assistant professor of Medicine at the Icahn School of Medicine at Mount Sinai.
Sue Friedman on Targeted Therapies and Knowing Family History of Cancer
June 13, 2019 – 
Genetic testing and understanding family history of cancer is important because more and more targeted therapies are coming out that are designed to work with specific mutations or inherited forms of mutations, said Sue Friedman, DVM, executive director of FORCE: Facing Our Risk of Cancer Empowered.
Paul Melmeyer on Willingness to Pay for High Cost of Rare Disease Therapies Among Stakeholders
June 10, 2019 – 
There is generally a greater willingness to pay among just about everybody for rare disease therapies, explained Paul Melmeyer, director of Federal Policy, National Organization for Rare Disorders.
David Ortiz Explains How OCM Is Changing Cancer Care Delivery
June 09, 2019 – 
The Oncology Care Model (OCM) is pushing cancer centers and cancer programs to make the changes they knew were needed to improve care delivery and patient experiences, said David Ortiz, OCM program director at Montefiore Einstein Center for Cancer Care.
Podcast: This Week in Managed Care—New Diabetes Cases on the Decline and Other Health News
June 09, 2019 – 
Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
Dr Jeanne Tie on How ctDNA Helps Guide Decisions in Cancer Care
June 08, 2019 – 
Circulating tumor DNA (ctDNA) can now allow clinicians to better understand which patients are at high risk of recurrence and should be offered intensified chemotherapy, said Jeanne Tie, MBChB, FRACP, MD, medical oncologist and associate professor at the Walter+Eliza Hall Institute of Medical Research.
Dr Eric Anderson on Wearable Technology in Parkinson Disease
June 07, 2019 – 
Eric Anderson, MD, PhD, vice chair of neurology, quality at SOC Telemed, discusses the growing field of wearable technology for movement disorders like Parkinson disease.
Dr Bruce Feinberg Discusses Speculation of the End of Chemotherapy in Cancer
June 06, 2019 – 
There has been much speculation about the end of chemotherapy in cancer treatment, but it’s not clear how accurate that is, said Bruce Feinberg, DO, vice president and chief medical officer of Cardinal Health Specialty Solutions.
Kellie Rodriguez Discusses Person-Centered Factors Driving Diabetes Outcomes
June 04, 2019 – 
The person-centered factors that drive outcomes in diabetes requires hospital systems that can actually address those needs, said Kellie Rodriguez, RN, MSN, MBA, CDE, director, Global Diabetes Program, Parkland Health & Hospital System.
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.